Cargando…

Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model

BACKGROUND: Estrogen therapy has positively impact the treatment of several cancers, such as prostate, lung and breast cancers. Moreover, several groups have reported the importance of estrogen induced gene regulation in esophageal cancer (EC). This suggests that there could be a potential for estro...

Descripción completa

Detalles Bibliográficos
Autores principales: Essack, Magbubah, MacPherson, Cameron Ross, Schmeier, Sebastian, Bajic, Vladimir B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495646/
https://www.ncbi.nlm.nih.gov/pubmed/23101584
http://dx.doi.org/10.1186/1752-0509-6-135
_version_ 1782249540553801728
author Essack, Magbubah
MacPherson, Cameron Ross
Schmeier, Sebastian
Bajic, Vladimir B
author_facet Essack, Magbubah
MacPherson, Cameron Ross
Schmeier, Sebastian
Bajic, Vladimir B
author_sort Essack, Magbubah
collection PubMed
description BACKGROUND: Estrogen therapy has positively impact the treatment of several cancers, such as prostate, lung and breast cancers. Moreover, several groups have reported the importance of estrogen induced gene regulation in esophageal cancer (EC). This suggests that there could be a potential for estrogen therapy for EC. The efficient design of estrogen therapies requires as complete as possible list of genes responsive to estrogen. Our study develops a systems biology methodology using esophageal squamous cell carcinoma (ESCC) as a model to identify estrogen responsive genes. These genes, on the other hand, could be affected by estrogen therapy in ESCC. RESULTS: Based on different sources of information we identified 418 genes implicated in ESCC. Putative estrogen responsive elements (EREs) mapped to the promoter region of the ESCC genes were used to initially identify candidate estrogen responsive genes. EREs mapped to the promoter sequence of 30.62% (128/418) of ESCC genes of which 43.75% (56/128) are known to be estrogen responsive, while 56.25% (72/128) are new candidate estrogen responsive genes. EREs did not map to 290 ESCC genes. Of these 290 genes, 50.34% (146/290) are known to be estrogen responsive. By analyzing transcription factor binding sites (TFBSs) in the promoters of the 202 (56+146) known estrogen responsive ESCC genes under study, we found that their regulatory potential may be characterized by 44 significantly over-represented co-localized TFBSs (cTFBSs). We were able to map these cTFBSs to promoters of 32 of the 72 new candidate estrogen responsive ESCC genes, thereby increasing confidence that these 32 ESCC genes are responsive to estrogen since their promoters contain both: a/mapped EREs, and b/at least four cTFBSs characteristic of ESCC genes that are responsive to estrogen. Recent publications confirm that 47% (15/32) of these 32 predicted genes are indeed responsive to estrogen. CONCLUSION: To the best of our knowledge our study is the first to use a cancer disease model as the framework to identify hormone responsive genes. Although we used ESCC as the disease model and estrogen as the hormone, the methodology can be extended analogously to other diseases as the model and other hormones. We believe that our results provide useful information for those interested in genes responsive to hormones and in the design of hormone-based therapies.
format Online
Article
Text
id pubmed-3495646
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34956462012-11-13 Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model Essack, Magbubah MacPherson, Cameron Ross Schmeier, Sebastian Bajic, Vladimir B BMC Syst Biol Research Article BACKGROUND: Estrogen therapy has positively impact the treatment of several cancers, such as prostate, lung and breast cancers. Moreover, several groups have reported the importance of estrogen induced gene regulation in esophageal cancer (EC). This suggests that there could be a potential for estrogen therapy for EC. The efficient design of estrogen therapies requires as complete as possible list of genes responsive to estrogen. Our study develops a systems biology methodology using esophageal squamous cell carcinoma (ESCC) as a model to identify estrogen responsive genes. These genes, on the other hand, could be affected by estrogen therapy in ESCC. RESULTS: Based on different sources of information we identified 418 genes implicated in ESCC. Putative estrogen responsive elements (EREs) mapped to the promoter region of the ESCC genes were used to initially identify candidate estrogen responsive genes. EREs mapped to the promoter sequence of 30.62% (128/418) of ESCC genes of which 43.75% (56/128) are known to be estrogen responsive, while 56.25% (72/128) are new candidate estrogen responsive genes. EREs did not map to 290 ESCC genes. Of these 290 genes, 50.34% (146/290) are known to be estrogen responsive. By analyzing transcription factor binding sites (TFBSs) in the promoters of the 202 (56+146) known estrogen responsive ESCC genes under study, we found that their regulatory potential may be characterized by 44 significantly over-represented co-localized TFBSs (cTFBSs). We were able to map these cTFBSs to promoters of 32 of the 72 new candidate estrogen responsive ESCC genes, thereby increasing confidence that these 32 ESCC genes are responsive to estrogen since their promoters contain both: a/mapped EREs, and b/at least four cTFBSs characteristic of ESCC genes that are responsive to estrogen. Recent publications confirm that 47% (15/32) of these 32 predicted genes are indeed responsive to estrogen. CONCLUSION: To the best of our knowledge our study is the first to use a cancer disease model as the framework to identify hormone responsive genes. Although we used ESCC as the disease model and estrogen as the hormone, the methodology can be extended analogously to other diseases as the model and other hormones. We believe that our results provide useful information for those interested in genes responsive to hormones and in the design of hormone-based therapies. BioMed Central 2012-10-26 /pmc/articles/PMC3495646/ /pubmed/23101584 http://dx.doi.org/10.1186/1752-0509-6-135 Text en Copyright ©2012 Essack et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Essack, Magbubah
MacPherson, Cameron Ross
Schmeier, Sebastian
Bajic, Vladimir B
Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title_full Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title_fullStr Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title_full_unstemmed Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title_short Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
title_sort identification of estrogen responsive genes using esophageal squamous cell carcinoma (escc) as a model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495646/
https://www.ncbi.nlm.nih.gov/pubmed/23101584
http://dx.doi.org/10.1186/1752-0509-6-135
work_keys_str_mv AT essackmagbubah identificationofestrogenresponsivegenesusingesophagealsquamouscellcarcinomaesccasamodel
AT macphersoncameronross identificationofestrogenresponsivegenesusingesophagealsquamouscellcarcinomaesccasamodel
AT schmeiersebastian identificationofestrogenresponsivegenesusingesophagealsquamouscellcarcinomaesccasamodel
AT bajicvladimirb identificationofestrogenresponsivegenesusingesophagealsquamouscellcarcinomaesccasamodel